Ensoma

📍 Boston, United States👥 118 employees💰 Last funded Jun 2023
Biotechnology Research🌐 ensoma.com
Website LinkedIn
Ensoma /en’sōmə/ is derived from the Greek phrase “en soma,” meaning in the body. We develop one-time in vivo treatments that precisely engineer any or all blood and immune cells to cure diseases from within. We have a bigger, bolder vision for genomic medicine: treatments as versatile, precise, and far-reaching as the body’s own cells. Our team takes inspired action towards pushing beyond today’s possible with the goal of delivering a one-time, off-the-shelf treatment to patients everywhere.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
1
Canada
1
United Kingdom
1
Investor activity2019–2023 · investors recorded per year
201912021120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Ensoma?
Ensoma has 3 investors on record on gritt.io.
When did Ensoma last raise funding?
The most recent investment in Ensoma recorded on gritt.io was in June 2023.
What industry is Ensoma in?
Ensoma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ensoma based?
Ensoma is headquartered in Boston, United States.